MAPT and Alzheimer disease: Other support comes from a study by Tarawneh et al. (2011) [332], where CSF VILIP-1 levels correlated with CSF p-tau-181 and t-tau proteins, which differentiated individuals with Alzheimer’s disease from other types of dementias.